KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exact Sciences (EXAS) Net Income (2016 - 2025)

Exact Sciences (EXAS) has disclosed Net Income for 16 consecutive years, with -$86.0 million as the latest value for Q4 2025.

  • On a quarterly basis, Net Income rose 90.05% to -$86.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$208.0 million, a 79.78% increase, with the full-year FY2025 number at -$208.0 million, up 79.78% from a year prior.
  • Net Income was -$86.0 million for Q4 2025 at Exact Sciences, down from -$19.6 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of $794000.0 in Q3 2023 to a low of -$864.6 million in Q4 2024.
  • A 5-year average of -$133.0 million and a median of -$93.6 million in 2025 define the central range for Net Income.
  • Peak YoY movement for Net Income: skyrocketed 100.53% in 2023, then crashed 4915.62% in 2024.
  • Exact Sciences' Net Income stood at -$220.6 million in 2021, then surged by 42.09% to -$127.7 million in 2022, then skyrocketed by 61.04% to -$49.8 million in 2023, then tumbled by 1637.25% to -$864.6 million in 2024, then skyrocketed by 90.05% to -$86.0 million in 2025.
  • Per Business Quant, the three most recent readings for EXAS's Net Income are -$86.0 million (Q4 2025), -$19.6 million (Q3 2025), and -$1.2 million (Q2 2025).